Stocks to Watch: Vyant Bio, Geron, Homology Medicines and Personalis Stocks to Watch: Vyant Bio, Geron, Homology Medicines and Personalis...…
Why Geron Stock Is Falling After Hours Geron Corp (NASDAQ: GERN) shares are trading lower in Wednesday's after-hours session after the company announced a read more...…
Geron Announces Public Stock Offering Of $175 Mln, Shares Slip 9% WASHINGTON (dpa-AFX) - Shares of Geron Corporation (GERN) slipped nearly 9% in extended hours on Wednesday after the late-stage clinical…
Geron Shares Fall 9.1% After Hours on Proposed $175M Stock Offering Geron Shares Fall 9.1% After Hours on Proposed $175M Stock Offering...…
Geron dips 8.5% on $175M public offering Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K GERON CORP For: Jan 04 Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Geron Shares Rise After Positive Trial Results for Imetelstat Geron Shares Rise After Positive Trial Results for Imetelstat...…
Thinking about buying stock in Geron Corp, InMed Pharmaceuticals, Kingsoft Cloud, Vivos Therapeutics, or Baozun? NEW YORK, Jan. 4, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GERN, INM, KC, VVOS, and BZUN. To…
Geron Imetelstat Trial In Lower Risk MDS Meets Primary Efficacy Goal; Stock Climbs In Pre-market WASHINGTON (dpa-AFX) - Geron Corp. (GERN), a late-stage clinical biopharmaceutical company, announced Wednesday positive top-line results from its IMerge Phase…
Geron Sees Positive Results From Imetelstat Trial Geron Sees Positive Results From Imetelstat Trial...…
Form 8-K GERON CORP For: Dec 21 Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 10-Q GERON CORP For: Sep 30 Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Geron (GERN) Q3 2022 Earnings Call Transcript GERN earnings call for the period ending September 30, 2022....…
Geron Corporation Q3 Loss increases, misses estimates WASHINGTON (dpa-AFX) - Geron Corporation (GERN) released Loss for its third quarter that increased from last year and missed the…
Geron GAAP EPS of -$0.10 misses by $0.01, revenue of $0.3M beats by $0.21M Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Geron draws Outperform rating at Wedbush on prospects for blood disease therapy Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…